Re N Agade Therapeutics Appoints Laurie Stelzer As Chief Financial Officer

Sep 12, 2023•almost 2 years ago

Position

Chief Financial Officer

Company

ReNAgade Therapeutics

Laurie Stelzer

Cambridge

Description

CAMBRIDGE, Mass.–– ReNAgade Therapeutics , a company unlocking the limitless potential for RNA medicines , today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgade’s leadership team.

Company Information

Company

ReNAgade Therapeutics

Location

Cambridge, Massachusetts, United States

About

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines. To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Joe hidden

hidden

Laurie hidden